Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Mar 2026 is -28.87% vs 79.28% in Mar 2025
Consolidate Net Profit
YoY Growth in quarter ended Mar 2026 is -18.35% vs 243.48% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Mar 2026 is -41.21% vs 133.61% in Mar 2025
Interest
YoY Growth in quarter ended Mar 2026 is -57.89% vs 35.71% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025
Compare Quarterly Results Of Teyi Pharmaceutical Group Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Mar 2026 is -9.80% vs 15.94% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -28.87% vs 79.28% in Mar 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is 56.36% vs -39.34% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -18.35% vs 243.48% in Mar 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Mar 2026 is 37.92% vs -38.93% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -41.21% vs 133.61% in Mar 2025
Quarterly - Interest
QoQ Growth in quarter ended Mar 2026 is 33.33% vs 0.00% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -57.89% vs 35.71% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025






